Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic.
Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 16628 Prague, Czech Republic.
Int J Mol Sci. 2022 Jan 10;23(2):721. doi: 10.3390/ijms23020721.
Congenital fibrinogen disorders are caused by mutations in genes coding for fibrinogen and may lead to various clinical phenotypes. Here, we present a functional and structural analysis of 4 novel variants located in the gene coding for fibrinogen Bβ chain-heterozygous missense BβY416C and BβA68S, homozygous nonsense BβY345*, and heterozygous nonsense BβW403* mutations. The cases were identified by coagulation screening tests and further investigated by various methods. Fibrin polymerization had abnormal development with decreased maximal absorbance in all patients. Plasmin-induced fibrin degradation revealed different lytic phases of BβY416C and BβW403* than those of the control. Fibrinopeptide cleavage measured by reverse phase high pressure liquid chromatography of BβA68S showed impaired release of fibrinopeptide B. Morphological properties, studied through scanning electron microscopy, differed significantly in the fiber thickness of BβY416C, BβA68S, and BβW403*, and in the fiber density of BβY416C and BβW403*. Finally, homology modeling of BβA68S showed that mutation caused negligible alternations in the protein structure. In conclusion, all mutations altered the correct fibrinogen function or structure that led to congenital fibrinogen disorders.
先天性纤维蛋白原异常是由纤维蛋白原基因编码突变引起的,可能导致各种临床表型。在此,我们对位于纤维蛋白原 Bβ 链编码基因中的 4 个新变体进行了功能和结构分析,包括杂合子错义 BβY416C 和 BβA68S、纯合子无义 BβY345和杂合子无义 BβW403突变。通过凝血筛选试验发现这些病例,并通过各种方法进一步研究。所有患者的纤维蛋白聚合均存在异常发育,最大吸光度降低。纤溶酶诱导的纤维蛋白降解显示 BβY416C 和 BβW403与对照相比具有不同的裂解相。通过反相高压液相色谱法测量的 BβA68S 的纤维蛋白肽 B 释放显示释放受损。通过扫描电子显微镜研究的形态特性在 BβY416C、BβA68S 和 BβW403的纤维厚度以及 BβY416C 和 BβW403*的纤维密度方面有显著差异。最后,BβA68S 的同源建模表明突变对蛋白质结构几乎没有影响。总之,所有突变都改变了纤维蛋白原的正常功能或结构,导致先天性纤维蛋白原异常。